Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 300/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Itraconazole |
Appearance | White Powder |
CAS NO. | 84625-61-6 |
Molecular Formula | C35H38Cl2N8O4 |
Storage | Keep in a cool, dry, dark location |
Antifungal Treatment: Itraconazole is primarily used for the treatment of various fungal infections, including but not limited to systemic mycoses, dermatomycoses, and onychomycosis.
Immunocompromised Patients: It is prescribed for immunocompromised individuals, such as those with HIV/AIDS or undergoing chemotherapy, who are more susceptible to fungal infections.
Preventive Therapy: Itraconazole can also be employed as a prophylactic agent to prevent fungal infections in high-risk individuals or in settings where exposure to fungi is anticipated.
Inhibition of Fungal Cell Membrane Synthesis: By inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes, itraconazole disrupts membrane integrity and function, leading to fungal cell death.
Broad-Spectrum Activity: Its mechanism of action enables itraconazole to exhibit broad-spectrum antifungal activity against a wide range of fungal species, including yeasts, molds, and dermatophytes.
Oral Bioavailability: Administered orally, itraconazole achieves good bioavailability, allowing it to reach therapeutic concentrations in the bloodstream and distribute throughout the body, making it effective against systemic and deep-seated fungal infections.
Hot-selling Nootropics | |||
Nooglutyl | Compound 7P | Noopept,GVS-111 | Piracetam |
Aniracetam | Nefiracetam | Pramiracetam | Fasoracetam |
Unifiram | Sunifiram | Coluracetam | N-Methyl-D-aspartic acid(NMDA) |
Alpha GPC | CR L-40,941 | Citicoline | Galantamine Hydrobromide |
PRL-8-53 | NSI-189 PhosphAte | NSI-189 | J-147 |
IDRA21 | Citicoline Sodium | PPH | N-acetyl-L-cysteine ethyl ester |